ℹ️
🇬🇧
Search
Search for people relevant for "mantle-cell lymphoma"
mantle-cell lymphoma
Person
Class
Person
Publication
Programmes
Export current view
prof. MUDr. Pavel Klener Ph.D.
Academic staff at First Faculty of Medicine
112 publications
Publications
publication
Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years
2016 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Single-agent cytarabine is insufficient for the treatment of human mantle cell lymphoma in mouse xenograft model
2016 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
2016 |
First Faculty of Medicine, Faculty of Physical Education and Sport
publication
Lenalidomide enhances antitumor functions of chimeric antigen receptor modified T cells
2016 |
First Faculty of Medicine
publication
Pevonedistat, a NEDD8-activating enzyme inhibitor, is active in mantle cell lymphoma and enhances rituximab activity in vivo
2016 |
First Faculty of Medicine
publication
The use of formalin-fixed, paraffin-embedded lymph node samples for the detection of minimal residual disease in mantle cell lymphoma
2015 |
First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
publication
Detailed Functional and Proteomic Characterization of Fludarabine Resistance in Mantle Cell Lymphoma Cells
2015 |
First Faculty of Medicine
publication
Mantle Cell Lymphoma - Cutting- edge Dia-gnostics and Treatment Approaches
2015 |
First Faculty of Medicine
publication
Mouse models of mantle cell lymphoma, complex changes in gene expression and phenotype of engrafted MCL cells: implications for preclinical research
2014 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové
publication
Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents
2014 |
First Faculty of Medicine
Load more publications (102)
Loading network view...